NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Protagonist Therapeutics Inc (STU: PGF)

 
PGF Technical Analysis
5
As on 22nd Sep 2021 PGF STOCK Price closed @ 19.13 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 25.16 & Strong Sell for SHORT-TERM with Stoploss of 17.51 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PGFSTOCK Price

Open 19.05 Change Price %
High 19.15 1 Day -13.71 -90.20
Low 19.02 1 Week -11.61 -88.63
Close 19.13 1 Month -39.11 -96.33
Volume 240400 1 Year -15.71 -91.34
52 Week High 42.80 | 52 Week Low 1.49
 
STU Germany Most Active Stocks
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
RUOC 0.14 0.00%
RUOC 0.14 0.00%
TINC 0.01 -1.50%
PGF 19.13 -90.20%
PGF 19.13 -90.20%
 
STU Germany Top Gainers Stocks
PPK 0.03 36625.00%
PPK 0.03 36625.00%
PPK 0.03 36625.00%
LNK 8.72 3388.00%
LNK 8.72 3388.00%
LNK 8.72 3388.00%
LNK 8.72 3388.00%
LNK 8.72 3388.00%
PCBK 10.60 2020.00%
PCBK 10.60 2020.00%
 
STU Germany Top Losers Stocks
LCJ 17.50 -100.00%
LCJ 17.50 -100.00%
LCJ 17.50 -100.00%
LCJ 17.50 -100.00%
LCJ 17.50 -100.00%
SB3 18.20 -100.00%
SB3 18.20 -100.00%
SB3 18.20 -100.00%
SB3 18.20 -100.00%
SB3 18.20 -100.00%
 
 
PGF
Daily Charts
PGF
Intraday Charts
Whats New @
Bazaartrend
PGF
Free Analysis
 
PGF Important Levels Intraday
SUPPORT1.62
SUPPORT1.58
SUPPORT1.55
SUPPORT1.53
SUPPORT1.45
SUPPORT1.43
SUPPORT1.40
SUPPORT1.36
 
PGF Forecast November 2024
4th UP Forecast8.81
3rd UP Forecast6.46
2nd UP Forecast5.01
1st UP Forecast3.56
1st DOWN Forecast-0.58
2nd DOWN Forecast-2.03
3rd DOWN Forecast-3.48
4th DOWN Forecast-5.83
 
PGF Weekly Forecast
4th UP Forecast4.38
3rd UP Forecast3.45
2nd UP Forecast2.88
1st UP Forecast2.31
1st DOWN Forecast0.67
2nd DOWN Forecast0.10
3rd DOWN Forecast-0.47
4th DOWN Forecast-1.40
 
PGF Forecast2024
4th UP Forecast81.13
3rd UP Forecast55.59
2nd UP Forecast39.8
1st UP Forecast24.01
1st DOWN Forecast-21.03
2nd DOWN Forecast-36.82
3rd DOWN Forecast-52.61
4th DOWN Forecast-78.15
 
Protagonist Therapeutics Inc ( STU Germany Symbol : PGF )
Sector : N/A And Other Stocks in Same Sector
 
PGF Other Details
Segment EQ
Market Capital 726438400.00
Sector
Industry
Offical website >
 
PGF Address
PGF
 
PGF Latest News
 
Your Comments and Response on Protagonist Therapeutics Inc
 
PGF Business Profile
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PTG-200, an oral, interleukin-23 receptor specific antagonist peptide, which is in phase II clinical trial for the treatment of moderate-to-severe Crohn's disease; and PN-943, an oral, alpha-4-beta-7 specific integrin antagonist that is in Phase II clinical trial for treating inflammatory bowel disease (IBD). The company has a license and collaboration agreement with Janssen Biotech, Inc. for the development, manufacture, and commercialization of PTG-200 for the treatment of Crohn's disease and ulcerative colitis; and PN-235 and PN-232 oral interleukin-23 receptor antagonist candidates for IBD and non-IBD indications. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California. Address: 7707 Gateway Boulevard, Newark, CA, United States, 94560-1160
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service